Logo image of ALTHE.PA

THERACLION (ALTHE.PA) Stock Fundamental Analysis

EPA:ALTHE - Euronext Paris - Matif - FR0010120402 - Common Stock - Currency: EUR

0.19  +0 (+2.43%)

Fundamental Rating

2

Overall ALTHE gets a fundamental rating of 2 out of 10. We evaluated ALTHE against 55 industry peers in the Health Care Equipment & Supplies industry. The financial health of ALTHE is average, but there are quite some concerns on its profitability. ALTHE has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ALTHE had negative earnings in the past year.
ALTHE had a negative operating cash flow in the past year.
ALTHE had negative earnings in each of the past 5 years.
In the past 5 years ALTHE always reported negative operating cash flow.
ALTHE.PA Yearly Net Income VS EBIT VS OCF VS FCFALTHE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -2M -4M -6M -8M

1.2 Ratios

ALTHE has a worse Return On Assets (-23.97%) than 70.91% of its industry peers.
The Return On Equity of ALTHE (-108.48%) is worse than 78.18% of its industry peers.
Industry RankSector Rank
ROA -23.97%
ROE -108.48%
ROIC N/A
ROA(3y)-29.03%
ROA(5y)-32.04%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALTHE.PA Yearly ROA, ROE, ROICALTHE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1K 2K 3K 4K

1.3 Margins

Looking at the Gross Margin, with a value of 102.48%, ALTHE belongs to the top of the industry, outperforming 96.36% of the companies in the same industry.
In the last couple of years the Gross Margin of ALTHE has grown nicely.
The Profit Margin and Operating Margin are not available for ALTHE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 102.48%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.36%
GM growth 5Y13.22%
ALTHE.PA Yearly Profit, Operating, Gross MarginsALTHE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400

More info and screens

4

2. Health

2.1 Basic Checks

ALTHE does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALTHE has more shares outstanding than it did 1 year ago.
ALTHE has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ALTHE has an improved debt to assets ratio.
ALTHE.PA Yearly Shares OutstandingALTHE.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
ALTHE.PA Yearly Total Debt VS Total AssetsALTHE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

2.2 Solvency

ALTHE has an Altman-Z score of 0.39. This is a bad value and indicates that ALTHE is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ALTHE (0.39) is worse than 63.64% of its industry peers.
A Debt/Equity ratio of 0.49 indicates that ALTHE is not too dependend on debt financing.
ALTHE has a Debt to Equity ratio of 0.49. This is comparable to the rest of the industry: ALTHE outperforms 47.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF N/A
Altman-Z 0.39
ROIC/WACCN/A
WACC7.1%
ALTHE.PA Yearly LT Debt VS Equity VS FCFALTHE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M -4M -6M -8M

2.3 Liquidity

A Current Ratio of 3.62 indicates that ALTHE has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.62, ALTHE belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
ALTHE has a Quick Ratio of 2.69. This indicates that ALTHE is financially healthy and has no problem in meeting its short term obligations.
ALTHE has a Quick ratio of 2.69. This is amongst the best in the industry. ALTHE outperforms 81.82% of its industry peers.
Industry RankSector Rank
Current Ratio 3.62
Quick Ratio 2.69
ALTHE.PA Yearly Current Assets VS Current LiabilitesALTHE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

More info and screens

0

3. Growth

3.1 Past

ALTHE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 43.54%, which is quite impressive.
Looking at the last year, ALTHE shows a very negative growth in Revenue. The Revenue has decreased by -31.40% in the last year.
Measured over the past years, ALTHE shows a decrease in Revenue. The Revenue has been decreasing by -1.13% on average per year.
EPS 1Y (TTM)43.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.68%
Revenue 1Y (TTM)-31.4%
Revenue growth 3Y34.8%
Revenue growth 5Y-1.13%
Sales Q2Q%-54.98%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year50%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALTHE.PA Yearly Revenue VS EstimatesALTHE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ALTHE.PA Yearly EPS VS EstimatesALTHE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALTHE. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 1.84, the valuation of ALTHE can be described as very cheap.
98.18% of the companies in the same industry are more expensive than ALTHE, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.10, ALTHE is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 1.84
ALTHE.PA Price Earnings VS Forward Price EarningsALTHE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALTHE.PA Per share dataALTHE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ALTHE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

THERACLION

EPA:ALTHE (3/7/2025, 7:00:00 PM)

0.19

+0 (+2.43%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)04-29 2025-04-29/amc
Inst Owners1.35%
Inst Owner ChangeN/A
Ins Owners18.68%
Ins Owner ChangeN/A
Market Cap8.80M
Analysts86.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 1.84
P/S 6.86
P/FCF N/A
P/OCF N/A
P/B 2.68
P/tB 4.18
EV/EBITDA N/A
EPS(TTM)-0.08
EYN/A
EPS(NY)0.1
Fwd EY54.21%
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0.03
BVpS0.07
TBVpS0.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -23.97%
ROE -108.48%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 102.48%
FCFM N/A
ROA(3y)-29.03%
ROA(5y)-32.04%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.36%
GM growth 5Y13.22%
F-Score3
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 3.37%
Cap/Sales 6.06%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.62
Quick Ratio 2.69
Altman-Z 0.39
F-Score3
WACC7.1%
ROIC/WACCN/A
Cap/Depr(3y)154.3%
Cap/Depr(5y)104.89%
Cap/Sales(3y)14.1%
Cap/Sales(5y)12.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)43.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.68%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-31.4%
Revenue growth 3Y34.8%
Revenue growth 5Y-1.13%
Sales Q2Q%-54.98%
Revenue Next Year50%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y50.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y59.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y59.18%
OCF growth 3YN/A
OCF growth 5YN/A